Código QR (código de barras bidimensional)

Comparative Efficacy and Safety of Biosimilar Bevacizumab (Stivant®) versus Reference Product (Avastin®) in Prethreshold Type I Retinopathy of Prematurity

Purpose: To compare the efficacy and safety of Stivant® (biosimilar bevacizumab, CinnaGen, Iran) to Avastin® (innovator bevacizumab, Genentech, South San Francisco, CA) in premature infants with prethreshold type I retinopathy of prematurity (ROP). Methods: Preterm infants with bilateral prethreshol...

Fuld beskrivelse

Na minha lista:
Principais autores: Mojtaba Abrishami, Zohreh Golmohammadi, Nasser Shoeibi, Mohammad-Reza Ansari-Astaneh, Mehdi Sakhayi, Majid Abrishami, Seyedeh Maryam Hosseini, Elham Bakhtiari, Mehrdad Motamed Shariati
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Medknow Publications 2024-10-01
Serier:Journal of Current Ophthalmology
Fag:
avastin
bevacizumab
efficacy
retinopathy of prematurity
safety
stivant
Online adgang:https://journals.lww.com/10.4103/joco.joco_178_24
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker